Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
Ramurthy S, Subramanian S, Aikawa M, Amiri P, Costales A, Dove J, Fong S, Jansen JM, Levine B, Ma S, McBride CM, Michaelian J, Pick T, Poon DJ, Girish S, Shafer CM, Stuart D, Sung L, Renhowe PA.
Ramurthy S, et al. Among authors: shafer cm.
J Med Chem. 2008 Nov 27;51(22):7049-52. doi: 10.1021/jm801050k.
J Med Chem. 2008.
PMID: 18942827